Next Article in Journal
Extrudate versus Powder Silica Alumina as Support for Re2O7 Catalyst in the Metathesis of Seed Oil-Derivatives – A Comparison
Next Article in Special Issue
Molecular Neuropathology of TDP-43 Proteinopathies
Previous Article in Journal
Determination of Aflatoxins in Peanut Products in the Northeast Region of São Paulo, Brazil
Previous Article in Special Issue
Terminal Continuation (TC) RNA Amplification Enables Expression Profiling Using Minute RNA Input Obtained from Mouse Brain
Int. J. Mol. Sci. 2009, 10(1), 184-212; doi:10.3390/ijms10010184

Molecular Neuropathology of Gliomas

Department of Neuropathology, Heinrich-Heine-University, Moorenstr. 5, 40225 Duesseldorf, Germany
* Author to whom correspondence should be addressed.
Received: 9 December 2008 / Revised: 2 January 2009 / Accepted: 5 January 2009 / Published: 7 January 2009
(This article belongs to the Special Issue Advances in Molecular Neuropathology)
View Full-Text   |   Download PDF [624 KB, uploaded 19 June 2014]   |   Browse Figures


Gliomas are the most common primary human brain tumors. They comprise a heterogeneous group of benign and malignant neoplasms that are histologically classified according to the World Health Organization (WHO) classification of tumors of the nervous system. Over the past 20 years the cytogenetic and molecular genetic alterations associated with glioma formation and progression have been intensely studied and genetic profiles as additional aids to the definition of brain tumors have been incorporated in the WHO classification. In fact, first steps have been undertaken in supplementing classical histopathological diagnosis by the use of molecular tests, such as MGMT promoter hypermethylation in glioblastomas or detection of losses of chromosome arms 1p and 19q in oligodendroglial tumors. The tremendous progress that has been made in the use of array-based profiling techniques will likely contribute to a further molecular refinement of glioma classification and lead to the identification of glioma core pathways that can be specifically targeted by more individualized glioma therapies.
Keywords: Glioblastoma; oligodendroglioma; ependymoma; molecular diagnostics; genetics; MGMT; 1p; 19q; biomarker; profiling Glioblastoma; oligodendroglioma; ependymoma; molecular diagnostics; genetics; MGMT; 1p; 19q; biomarker; profiling
This is an open access article distributed under the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
MDPI and ACS Style

Riemenschneider, M.J.; Reifenberger, G. Molecular Neuropathology of Gliomas. Int. J. Mol. Sci. 2009, 10, 184-212.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


Cited By

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert